Erasca, Inc.

NasdaqGS:ERAS Rapport sur les actions

Capitalisation boursière : US$768.1m

Erasca Dividende

Dividende contrôle des critères 0/6

Erasca does not have a record of paying a dividend.

Informations clés

n/a

Rendement du dividende

-28.5%

Rendement des rachats

Rendement total pour l'actionnaire-28.5%
Rendement futur des dividendes0%
Croissance des dividendesn/a
Prochaine date de paiement du dividenden/a
Date ex-dividenden/a
Dividende par actionn/a
Ratio de distributionn/a

Mises à jour récentes des dividendes

Pas de mise à jour

Recent updates

We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Oct 15
We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Erasca: New Focus After Restructuring, But Need More Differentiation

Sep 30

Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?

Feb 21
Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?

We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully

Nov 16
We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully

Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth

Jun 28
Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth

We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Jan 20
We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Erasca forms clinical trial partnership with Pfizer for cancer therapy

Oct 20

Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Sep 23
Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Erasca adds 10% ahead of R&D Day

Sep 07

Erasca, Eli Lilly to collaborate on trial to evaluate combo treatment for two cancers

Jul 18

We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate

Apr 12
We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate

Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Dec 28
Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Stabilité et croissance des paiements

Récupération des données sur les dividendes

Dividende stable: Insufficient data to determine if ERAS's dividends per share have been stable in the past.

Dividende croissant: Insufficient data to determine if ERAS's dividend payments have been increasing.


Rendement des dividendes par rapport au marché

Erasca Rendement des dividendes par rapport au marché
Comment le rendement du dividende de ERAS se compare-t-il à celui du marché ?
SegmentRendement du dividende
Entreprise (ERAS)n/a
25% du marché (US)1.5%
25% du marché (US)4.5%
Moyenne du secteur (Biotechs)2.2%
Analyste prévisionnel (ERAS) (jusqu'à 3 ans)0%

Dividende notable: Unable to evaluate ERAS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Dividende élevé: Unable to evaluate ERAS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Bénéfice distribué aux actionnaires

Couverture des revenus: Insufficient data to calculate ERAS's payout ratio to determine if its dividend payments are covered by earnings.


Paiement en espèces aux actionnaires

Couverture des flux de trésorerie: Unable to calculate sustainability of dividends as ERAS has not reported any payouts.


Découvrir des entreprises qui versent des dividendes élevés